Comparative study of IgA nephropathy with and without crescents

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 9, 2004, Pages 1373-1377

  Bitencourt Dias, Cristiane ^a,b   Bahiense Oliveira, M ^a   Saldanha, L B ^a   Barros, R T ^a   Woronik, V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Creatinine; Crescents; End stage renal disease; IgA nephropathy; Renal failure

Indexed keywords

CREATININE; IMMUNOGLOBULIN A; PROTEIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN URINE LEVEL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RETROSPECTIVE STUDY; URINARY EXCRETION;

EID: 4444279482     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2004000900012     Document Type: Article

References (28)

1. Julian BA, Waldo B, Rifai A & Mestecky J (1988). IgA nephropathy, the most common glomerulonephritis worldwide. American Journal of Medicine, 4: 129-132.
2. D'Amico G (1987). The commonest glomerulonephritis in the world: IgA nephropathy. Quarterly Journal of Medicine, 64: 709-727.
3. Simon P, Ramée MP, Autuly V, Laruelle E, Charasse C, Cam G & Ang KS (1994). Epidemiology of primary glomerular diseases in a French region. Variations according to period and age. Kidney International, 46: 192-198.
4. Schena FP (1997). Italian group of renal immunopathology. Survey of the Italian registry of renal biopsies. Frequency of the renal diseases for 7 consecutive years. Nephrology, Dialysis, Transplantation, 12: 418-426.
5. Research Group on Progressive Chronic Renal Disease (1999). Nationwide and long-term survey of primary glomerulonephritis in Japan as observed in 1,850 biopsied cases. Nephron, 82: 205-223.
6. Mazzuchi N & Di Martino LA (1997). Epidemiología de las glomerulopatias primárias en el Uruguay. Archivio di Medicina Interna, 19: 21-26.
7. Haas M, Meehan SM, Kadison TG & Spargo BH (1997). Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. American Journal of Kidney Diseases, 30: 621-631.
8. Bahiense-Oliveira M, Malafronte P & Barros RT (2002). Aspectos epidemiológicos das glomerulopatias no Brasil. In: Cruz J, Mazzarolo-Cruz HM & Barros RT (Editors), Atualidades em Nefrologia 7. Sarvier, São Paulo, SP, Brazil, 73-77.
9. Floege J & Feehally J (2000). IgA nephropathy: recent developments. Journal of the American Society of Nephrology, 11: 2395-2403.
10. Galla JH (1995). IgA nephropathy. Kidney International, 45: 377-387.
11. Noris M & Remuzzi G (1999). IgA nephropathy: a stem cell disease? Kidney International, 56: 1964-1966.
12. Allen AC, Bailet EM, Brenchley PE, Buck KS, Barratt J & Feehally J (2001). Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney International, 60: 969-973.
13. Roccatello D, Picciotto G, Torchio M et al. (1993). Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asiliglycoprotein receptors. Laboratory Investigation, 69: 714-723.
14. Bahiense-Oliveira M, Mota ELA, Saldanha LB, Penna DO, Barros RT & Romão Jr JE (2004). Primary glomerular diseases in Brazil: is the frequency of focal and segmental glomerulosclerosis increasing? Clinical Nephrology (in press).
15. D'Amico G (2000). Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. American Journal of Kidney Diseases, 36: 227-237.
16. Bartosik LP, Lajoie G, Sugar L & Cattran DC (2001). Predicting progression in IgA nephropathy. American Journal of Kidney Diseases, 38: 728-735.
17. Haas M (1997). Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. American Journal of Kidney Diseases, 29: 829-842.
18. Maisonneuve P, Agodoa L, Gallert R et al. (2000). Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe and Australia/New Zealand: results from a comparative study. American Journal of Kidney Diseases, 35: 157-163.
19. Registro Paulista de Glomerulopatias (2001). Brazilian glomerulonephritis registry: analysis of a regional multicentre study in State of São Paulo. Journal of the American Society of Nephrology, 12: 114A.
20. Emancipator SN (1998). IgA nephropathy and Henoch-Schönlein syndrome. In: Jennette JC, Olson JL, Schwartz MW & Silva FG (Editors), Heptinstall's Pathology of the Kidney. Lippincott-Raven, Philadelphia, PA, USA.
21. Hogg RJ, Silva FG, Wyatt RJ, Reisch JS, Argyle JC & Savino DA (1994). Prognostic indicators in children with IgA nephropathy - Report of the Sowthwest Pediatric Nephrology Study Group. Pediatric Nephrology, 8: 15-20.
22. Yoshikawa N, Ito H & Nakamura H (1992). Prognostic indicators in childhood IgA nephropathy. Nephron, 60: 60-67.
23. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN) (1998). Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy, Lancet, 352: 1252-1256.
24. Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M & Balletta MM (2001). Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. American Journal of Kidney Diseases, 38: 18-25.
25. Pozzi C, Bolasco PG, Fogazzi GB, Androlli S, Altieri P, Ponticelli C & Locatelli F (1999). Corticosteroids in IgA nephropathy: A randomised controlled trial. Lancet, 353: 883-887.
26. Ballardie FW & Roberts IS (2002). Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. Journal of the American Society of Nephrology, 13: 142-148.
27. McIntyre CW, Fluck RJ & Lambie SH (2001). Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment. Clinical Nephrology, 56: 193-198.
28. Tumlin JA, Lahavichan V & Hennigar R (2003). Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide. Nephrology, Dialysis, Transplantation, 18: 1321-1329.